Patent · US Active

Humanized antibodies

US10647756B2 · kind B2 · utility

2Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2016
Grant dateMay 12, 2020
Priority date—
Expiry dateDec 30, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein are humanized antibodies in which human germline residues are introduces to the complementarity determining regions (CDRs) of a non-human donor antibody. Also described herein are libraries of antibody variable domains (e.g., phage-display libraries) and methods for screening for humanized antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.